Magnesium metabolism in insulin resistance, metabolic syndrome, and type 2 diabetes mellitus

New Perspectives in Magnesium Research: Nutrition and Health

Volumn , Issue , 2007, Pages 213-223

  Barbagallo, Mario ^a   Dominguez, Ligia J ^a   Brucato, Virna ^a   Galioto, Antonio ^a   Pineo, Antonella ^a   Ferlisi, Anna ^a   Tranchina, Ernesto ^a   Belvedere, Mario ^a   Putignano, Ernesto ^a   Costanza, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895407476     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-483-0_17     Document Type: Chapter

References (53)

1. Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003;24: 39-52
2. Barbagallo M, Resnick LM. Calcium and magnesium in the regulation of smooth muscle function and blood pressure: The ionic hypothesis of cardiovascular and metabolic diseases and vascular aging. In: Sowers JR, ed. Endocrinology of the Vasculature. 1st ed. Totowa, NJ: Humana Press; 1996:283-300
3. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X". Am J Hypertens 1993;6: 123S-134S.
4. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294: 1-26
5. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:767-770
6. 2+. Scand J Clin Lab Invest Suppl 1994;217:53-67
7. 2+ in whole blood, serum and plasma. Methods Find Exp Clin Pharmacol 1992;14:297-304
8. Altura BT, Shirey TL, Young CC, et al. Characterization of a new ion selective electrode for ionized magnesium in whole blood, plasma, serum, and aqueous samples. Scand J Clin Lab Invest Suppl 1994;217:21-36
9. Kolterman OG, Gray RS, Griffin J, et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 1981;68:957-969
10. Laughlin MR, Thompson D. The regulatory role for magnesium in glycolytic fl ux of the human erythrocyte. J Biol Chem 1996;271:28977-28983
11. Barbagallo M, Resnick LM, Dominguez LJ, Licata G. Diabetes mellitus, hypertension and ageing: The ionic hypothesis of ageing and cardiovascular- metabolic diseases. Diabetes Metab 1997;23:281-294
12. Resnick LM. The cellular ionic basis of hypertension and allied clinical conditions. Prog Cardiovasc Dis 1999;42:1-22
13. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-2159
14. Mather HM, Nisbet JA, Burton GH, et al. Hypomagnesaemia in diabetes. Clin Chim Acta 1979;95:235-242
15. Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-Term metabolic control. Diabetologia 1992;35:77-79
16. Sjogren A, Floren CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 1988;224:461-466
17. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I. Renal hypomagnesaemia in human diabetes mellitus: Its relation to glucose homeostasis. Eur J Clin Invest 1982;12:81-85
18. Djurhuus MS, Klitgaard NA, Pedersen KK, et al. Magnesium reduces insulinstimulated glucose uptake and serum lipid concentrations in type 1 diabetes. Metabolism 2001;50:1409-1417
19. Djurhuus MS. New data on the mechanisms of hypermagnesuria in type I diabetes mellitus. Magnes Res 2001;14:217-223
20. Matsunobu S, Terashima Y, Senshu T, Sano H, Itoh H. Insulin secretion and glucose uptake in hypomagnesemic sheep fed a low magnesium, high potassium diet. J Nutr Biochem 1990;1:167-171
21. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am J Hypertens 1997;10:346-355
22. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004;17:126-136
23. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension 1991;17:951-957
24. Resnick LM. Hypertension and abnormal glucose homeostasis. Possible role of divalent ion metabolism. Am J Med 1989;87:17S-22S
25. Barbagallo M, Gupta RK, Dominguez LJ, Resnick LM. Cellular ionic alterations with age: Relation to hypertension and diabetes. J Am Geriatr Soc 2000;48: 1111-1116
26. Resnick LM, Barbagallo M, Bardicef M, et al. Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: A nuclear magnetic resonance spectroscopic study. Hypertension 2004;44:322-326
27. Resnick LM, Bardicef O, Barbagallo M, et al. 31PNMR spectroscopic studies of oral glucose loading and in situ skeletal muscle ion content in essential hypertension. Hypertension 1995;26:552
28. Resnick LM, Gupta RK, Gruenspan H, Alderman MH, Laragh JH. Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. Am J Hypertens 1990;3:373-379
29. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of glutathione on red blood cell intracellular magnesium: Relation to glucose metabolism. Hypertension 1999;34:76-82
30. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of vitamin E and glutathione on glucose metabolism: Role of magnesium. Hypertension 1999;34:1002-1006
31. Rosolova H, Mayer O Jr, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000;49:418-420
32. Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 1997;82:3783-3785
33. Resnick LM. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: A unifying theme. J Am Soc Nephrol 1992;3:S78-S85
34. Barbagallo M, Resnick LM. The role of glucose in diabetic hypertension: Effects on intracellular cation metabolism. Am J Med Sci 1994;307(suppl 1):S60-S65
35. Resnick LM, Barbagallo M, Gupta RK, Laragh JH. Ionic basis of hypertension in diabetes mellitus. Role of hyperglycemia. Am J Hypertens 1993;6:413-417
36. Barbagallo M, Shan J, Pang PK, Resnick LM. Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J Clin Invest 1995;95:763-767
37. Barbagallo M, Dominguez LJ, Bardicef O, Resnick LM. Altered cellular magnesium responsiveness to hyperglycemia in hypertensive subjects. Hypertension 2001;38: 612-615
38. Barbagallo M, Gupta RK, Resnick LM. Independent effects of hyperinsulinemia and hyperglycemia on intracellular sodium in normal human red cells. Am J Hypertens 1993;6:264-267
39. Barbagallo M, Gupta RK, Resnick LM. Cellular ionic effects of insulin in normal human erythrocytes: A nuclear magnetic resonance study. Diabetologia 1993;36: 146-149
40. Barbagallo M, Gupta RK, Bardicef O, Bardicef M, Resnick LM. Altered ionic effects of insulin in hypertension: Role of basal ion levels in determining cellular responsiveness. J Clin Endocrinol Metab 1997;82:1761-1765
41. Nadler J, Scott S. Evidence that pioglitazone increases intracellular free magnesium concentration in freshly isolated rat adipocytes. Biochem Biophys Res Commun 1994;202:416-421
42. Dominguez LJ, Barbagallo M, Sowers JR, Resnick LM. Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab 1998;83:4402-4407
43. Guerrero-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res 2005;36:250-257
44. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trial. Diabetes Care 2003;26:1147-1152
45. Yokota K, Kato M, Lister F, et al. Clinical Efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 2004;23:506S-509S
46. Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994;78:1510-1514
47. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabetes Med 1998;15:503-507
48. Lima Mde L, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21:682-686
49. Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 1994;17:460-461
50. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253-258
51. Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134-140
52. McCarty MF. Nutraceutical resources for diabetes prevention -An update. Med Hypotheses 2005;64:151-158
53. Resnick LM. Magnesium in the pathophysiology and treatment of hypertension and diabetes mellitus: Where are we in 1997? Am J Hypertens 1997;10:368-370.